Skip to content
MedsAcross

Manufacturer

Umedica Laboratories

Pharmaceutical manufacturer based in India
Indian manufacturerIndia
Products listed
33
Molecules
12
Therapy areas
6

Umedica Laboratories is a pharmaceutical manufacturer based in India. MedsAcross lists 33 of its products across 12 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
India
Indian manufacturer
Yes
Also listed as
Umedica Laboratories USA Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Umedica Laboratories products through licensed channels, with the documents your regulator needs.

Neurology

10 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Carbamazepine 100 mg extended-release tabletOralGeneric nameCarbamazepineUS FDAAvailable on request
Carbamazepine 100 mg tabletOralGeneric nameCarbamazepineUS FDAAvailable on request
Carbamazepine 200 mg tabletOralGeneric nameCarbamazepineUS FDAAvailable on request
Carbamazepine 200 mg extended-release tabletOralGeneric nameCarbamazepineUS FDAAvailable on request
Carbamazepine 400 mg extended-release tabletOralGeneric nameCarbamazepineUS FDAAvailable on request
Oxcarbazepine 150 mg tabletOralGeneric nameOxcarbazepineUS FDAAvailable on request
Oxcarbazepine 300 mg tabletOralGeneric nameOxcarbazepineUS FDAAvailable on request
Oxcarbazepine 600 mg tabletOralGeneric nameOxcarbazepineUS FDAAvailable on request
Varenicline 0.5 mg tabletOralGeneric nameVareniclineUS FDAAvailable on request
Varenicline 1 mg tabletOralGeneric nameVareniclineUS FDAAvailable on request

Rheumatology

6 presentations

Rheumatology overview
MedicineActive ingredientRegisterAvailability
Diclofenac 25 mg tabletOralGeneric nameDiclofenacUS FDAAvailable on request
Diclofenac 25 mg delayed-release tabletOralGeneric nameDiclofenacUS FDAAvailable on request
Diclofenac 50 mg delayed-release tabletOralGeneric nameDiclofenacUS FDAAvailable on request
Diclofenac 50 mg powder for oral solutionOralGeneric nameDiclofenacUS FDAAvailable on request
Diclofenac 50 mg tabletOralGeneric nameDiclofenacUS FDAAvailable on request
Diclofenac 75 mg delayed-release tabletOralGeneric nameDiclofenacUS FDAAvailable on request

Nephrology and urology

5 presentations

Nephrology and urology overview
MedicineActive ingredientRegisterAvailability
Sildenafil 100 mg tabletOralGeneric nameSildenafilUS FDAAvailable on request
Sildenafil 25 mg tabletOralGeneric nameSildenafilUS FDAAvailable on request
Sildenafil 50 mg tabletOralGeneric nameSildenafilUS FDAAvailable on request
Tadalafil 10 mg tabletOralGeneric nameTadalafilUS FDAAvailable on request
Tadalafil 2.5 mg tabletOralGeneric nameTadalafilUS FDAAvailable on request

Cardiology

4 presentations

Cardiology overview
MedicineActive ingredientRegisterAvailability
Chlorthalidone 25 mg tabletOralGeneric nameChlorthalidoneUS FDAAvailable on request
Chlorthalidone 50 mg tabletOralGeneric nameChlorthalidoneUS FDAAvailable on request
Ranolazine 1000 mg extended-release tabletOralGeneric nameRanolazineUS FDAAvailable on request
Ranolazine 500 mg extended-release tabletOralGeneric nameRanolazineUS FDAAvailable on request

Psychiatry

3 presentations

Psychiatry overview
MedicineActive ingredientRegisterAvailability
Sertraline 150 mg capsuleOralGeneric nameSertralineUS FDAAvailable on request
Sertraline 200 mg capsuleOralGeneric nameSertralineUS FDAAvailable on request
Zolpidem 7.5 mg capsuleOralGeneric nameZolpidemUS FDAAvailable on request

Oncology

2 presentations

Oncology overview
MedicineActive ingredientRegisterAvailability
Celecoxib 400 mg capsuleOralGeneric nameCelecoxibUS FDAAvailable on request
Celecoxib 50 mg capsuleOralGeneric nameCelecoxibUS FDAAvailable on request

Other products

3 presentations

MedicineActive ingredientRegisterAvailability
Hydrochlorothiazide and Olmesartan 12.5 mg/20 mg tabletOralGeneric nameHydrochlorothiazide and OlmesartanUS FDAAvailable on request
Hydrochlorothiazide and Olmesartan 12.5 mg/40 mg tabletOralGeneric nameHydrochlorothiazide and OlmesartanUS FDAAvailable on request
Hydrochlorothiazide and Olmesartan 25 mg/40 mg tabletOralGeneric nameHydrochlorothiazide and OlmesartanUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Umedica Laboratories

Send a request for any of these products. We confirm the licensed source, documents and lead time.